Completing data — refresh the page later to see the latest
535-87-5Nc1cc(N)cc(C(=O)O)c1UENRXLSRMCSUSN-UHFFFAOYSA-NRN given refers to parent cpd
535-87-5DTXSID1044437CHEMBL337700Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 48 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Not Classified
Status: Cease Manufacture Update: 10-03-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/19028
Benzoic acid, 3,5-diamino-: Does not have an individual approval but may be used under an appropriate group standard
Uses3,5-diaminobenzoic acid be used as organic intermediates.
Uses3,5-Diaminobenzoic acid is an analog of diatriazoate, which has been shown to have antigenicity properties towards the monoclonal antibodies. It is used as pharmaceutical intermediate.